SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : WebMD Health Corp
WBMD 66.480.0%Sep 18 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
From: Glenn Petersen7/24/2017 9:10:34 AM
1 Recommendation

Recommended By
Sr K

   of 326
 
KKR to buy WebMD in $2.8 billion deal
  • KKR announced plans to acquire WebMD Health in an all-cash deal valued at about $2.8 billion.
  • WebMD shareholders will receive $66.50 per share in cash.
  • Prior to the acquisition WebMD ran a five-month auction and solicited bids from more than 100 companies and private-equity firms.
Reuters
July 24, 2019



Andrew Harrer | Bloomberg | Getty Images
The WebMD application is demonstrated on an Apple Inc. iPad Air.
________________________________

Online health publisher WebMD Health said on Monday it agreed to be bought by private equity firm KKR in a deal valued at about $2.8 billion.

The deal brings together WebMD's websites, such as WebMD.com, Medscape.com and MedicineNet.com, and those owned by KKR unit Internet Brands Inc, including DentalPlans.com and AllAboutCounseling.com.

KKR will pay $66.50 per share, a premium of 20.5 percent to WebMD's Friday closing price. WebMD's shares were trading at $66 before the opening bell.

Reuters reported on Sunday that KKR was nearing a deal to buy the online health information provider.

Founded in 1996, WebMD has grown into one of the most popular health websites for consumers and medical professionals, attracting more than 70 million monthly unique visitors in 2016, according to analytics company comScore Inc.

WebMD also owns medical news and education brand Medscape, which accounted for around 60 percent of its advertising revenue in 2016.

The New York-based company said in February it would explore its options, after a slowdown in advertising paid for by pharmaceutical companies.

The deal, approved by the WebMD board, is expected to close in the fourth quarter of 2017.

J.P. Morgan Securities LLC is WebMD's financial adviser, while Shearman & Sterling LLP is its legal adviser.

Simpson Thacher & Bartlett LLP is Internet Brands' legal adviser.

cnbc.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext